Discovery of Pyrrolopyrazine Carboxamide Derivatives as Potent and Selective FGFR2/3 Inhibitors that Overcome Mutant Resistance.
Wang Y, Zhang Y, Liu J, Zhao J, Wang C, Meng F, Cai X, Zhang M, Aliper A, Liang T, Yan F, Ren F, Lan J, Lu Q, Zhou F, Zhavoronkov A, Ding X.
Wang Y, et al. Among authors: zhou f.
J Med Chem. 2025 Jan 31. doi: 10.1021/acs.jmedchem.4c03205. Online ahead of print.
J Med Chem. 2025.
PMID: 39885813